livemint_markets5 days ago
NEUTRAL(90%)
hold
Sai Parenteral's IPO: From GMP to key dates, price band, peers and more - 10 key things to know before subscribing
Read original source+9
Market Impact Score
-100 Bearish+100 Bullish
AI Analysis
The Indian pharma sector is experiencing growth, with companies focusing on R&D and expansion. IPOs in this sector provide new investment avenues and reflect investor confidence.
Trading Insight
Monitor the IPO's subscription rates and grey market premium (GMP) for demand indicators, but exercise caution as IPOs can be volatile post-listing.
Quick check: SUNPHARMA neutral (+1.2% 1d), CIPLA bearish bias (oversold).
Key Evidence
- •Sai Parenteral's IPO opens on March 24, 2026.
- •The IPO aims to raise ₹409 crore.
- •The price band is set at ₹372-392 per share.
- •Funds will be used for expansion, R&D, and working capital.
- •Shares are expected to list on April 2, 2026.
AI-powered analysis by
Anadi Algo News